Clin2
NCT06812728Possibly a fitRecruiting

Chemo and radiation before surgery for advanced rectal cancer

Rectum Cancer

Treatments studied

Part of Cancer, Digestive system clinical trials.

This trial tests giving a strong chemotherapy combination (FOLFIRINOX) followed by radiation before surgery for locally advanced rectal cancer. If you have stage 3 or high-risk stage 2 rectal cancer that has not spread, this approach may shrink the tumor and improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have been diagnosed with rectal adenocarcinoma (a type of rectal cancer).
  • Your cancer is locally advanced (stage cT3 with high risk, cT4, or has spread to nearby lymph nodes) and has not spread to distant parts of the body.
  • Your cancer can be removed with surgery, or the doctors believe it could become removable after radiation and chemo.
  • You have good overall health (able to care for yourself, up and about) and no major heart, nerve, or other medical problems.
  • You have not had radiation to the pelvic area or certain chemotherapies before.
  • If you could become pregnant, you must use reliable birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03975049Not yet recruiting· Phase 3
Combination chemotherapy before surgery for locally advanced rectal cancer

This trial compares different combinations of chemotherapy drugs given before surgery to the standard approach of chemoradiation (chemotherapy plus radiation) for rectal cancer that has not spread. The goal is to see if the drug combinations are more effective at shrinking tumors and improving outcomes.

NCT06162650Recruiting· Phase 2
Pre-surgery chemo-radiation therapy for rectal cancer

This trial tests a combination of chemotherapy and radiation therapy before surgery for people with mid or low rectal cancer that hasn't spread. The goal is to see if this approach works better than current treatments.

Tainan
NCT04643366Recruiting· Phase 2
Total treatment with chemotherapy and short radiation before surgery

This trial tests whether combining chemotherapy (mFOLFOX6) and a short course of radiation before surgery improves outcomes for people with resectable rectal cancer. The goal is to shrink and control the cancer early and then remove it with curative surgery.

Richmond, Virginia
NCT06894797Recruiting
Chemo and radiation before and after surgery for rectal cancer

This study tests a sequence of chemotherapy and radiation before and after surgery for rectal cancer. It compares giving more chemo between the end of radiation and surgery (consolidation) versus giving some chemo before radiation starts (induction). The goal is to see which order works better.

Beijing
NCT03671252Recruiting· Phase 3
Chemotherapy before surgery for rectal cancer vs chemo with radiation

This Phase 3 trial compares two treatment plans given before rectal surgery. It tests whether stronger chemotherapy alone works better than chemotherapy pills plus long-term radiation to improve outcomes for locally advanced rectal cancer.

Guangzhou, Guangdong
NCT07472868Not yet recruiting· Phase 3
Comparing chemo combinations before surgery or watch-and-wait for rectal cancer

This trial compares two different chemotherapy combinations given before radiation or surgery for high-risk locally advanced rectal cancer. One arm is more intense, and the other is standard. The goal is to see which works better at shrinking the tumor and possibly avoiding surgery.

Eindhoven, North Brabant

Hear when a new Rectum Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.